PDL BioPharma Inc (NASDAQ:PDLI)

3.33
Delayed Data
As of Sep 18
 +0.095 / +2.94%
Today’s Change
1.68
Today|||52-Week Range
3.78
+25.87%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Monnet Dominique
President & Chief Executive Officer
Sale2/07/2020672,505$3.51$2.4M-4.99%
Hernday Natasha A
Sale2/07/202082,488$3.51$289.5K-4.99%
Stone Christopher Lewis
General Counsel, Secretary & Vice President
Sale12/16/20192,686$3.33$8.9K+0.45%
Stone Christopher Lewis
General Counsel, Secretary & Vice President
Sale12/12/20191,240$3.43$4.3K-2.77%
Jene Jill M
Vice President-Business Development
Gift1/08/2020194,805$0.00$0.00+8.28%
Monnet Dominique
President & Chief Executive Officer
Gift1/08/20201,233,766$0.00$0.00+8.28%
Stone Christopher Lewis
General Counsel, Secretary & Vice President
Gift1/08/2020422,078$0.00$0.00+8.28%
Hernday Natasha A
Gift1/08/2020292,208$0.00$0.00+8.28%
Stone Christopher Lewis
General Counsel, Secretary & Vice President
Gift1/08/2020422,078$0.00$0.00+8.28%
Jene Jill M
Vice President-Business Development
Gift1/08/2020194,805$0.00$0.00+8.28%
Page of 2